AMP Capital Investors’s Medifast MED Stock Holding History

AMP Capital Investors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-886	Closed	-$251K	–	1154
2021 Q2	$251K	Buy	+886	New	+$240K	﹤0.01%	1090
2021 Q1	–	Sell	-4,464	Closed	-$861K	–	1282
2020 Q4	$861K	Sell	4,464 -846	-16%	-$150K	﹤0.01%	881
2020 Q3	$858K	Buy	5,310 +840	+19%	+$138K	0.01%	842
2020 Q2	$610K	Buy	+4,470	New	+$410K	﹤0.01%	876
2018 Q4	–	Sell	-1,500	Closed	-$330K	–	1161
2018 Q3	$330K	Hold	1,500	–	–	﹤0.01%	1066
2018 Q2	$240K	Buy	+1,500	New	+$192K	﹤0.01%	1111
2017 Q4	–	Sell	-4,600	Closed	-$273K	–	1210
2017 Q3	$273K	Sell	4,600 -7,515	-62%	-$374K	﹤0.01%	1067
2017 Q2	$500K	Buy	12,115 +7,515	+163%	+$327K	﹤0.01%	981
2017 Q1	$202K	Buy	+4,600	New	+$198K	﹤0.01%	1130

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AMP Capital Investors's MED Position: Q3 2021 in Review

AMP Capital Investors sold out of Medifast (MED) in Q3 2021, closing a stake of 886 shares — an estimated $251K sold.

AMP Capital Investors first reported a position in MED in Q1 2017 and held it in 9 quarters. The position peaked at $861K in Q4 2020. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

AMP Capital Investors reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
AMP Capital Investors sold 886 Medifast shares in Q3 2021, an estimated $251K.
AMP Capital Investors first reported a position in Medifast in Q1 2017 and held it in 9 quarters.
AMP Capital Investors's Medifast position peaked at $861K in Q4 2020.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on AMP Capital Investors's 13F filing for Q3 2021, filed 15 Nov 2021.